PHILADELPHIA — John A. Dani, PhD, will become the new chair of the Department of Neuroscience in the Perelman School of Medicine, University of Pennsylvania, on July 1, 2013. He will also serve as Director of the Mahoney Institute of Neurosciences (MINS) at Penn.
“Given his impressive combination of research strength, administrative experience, and institutional citizenship, I am confident that Dr. Dani will not only be a great colleague to everyone, but will also ably lead the department and MINS to even greater levels of success,” said J. Larry Jameson, MD, PhD, dean of the Perelman School of Medicine and executive vice president of the University of Pennsylvania for the Health System.
Dani is currently professor of Neuroscience at Baylor College of Medicine in Houston, with secondary appointments in Baylor’s Menninger Department of Psychiatry and Behavioral Sciences and its Graduate Program in Translational Biology and Molecular Medicine. He is also director of Baylor’s Center on Addiction, Learning and Memory.
His research interests cover how behavior, addiction, learning, and memory cut across disciplines. With longtime support from the National Institute of Neurological Disorders and Stroke and the National Institute of Drug Abuse, Dani and his lab are among the leaders in studying nicotine and its role in addiction. For example, his team investigates how nicotine initiates cellular mechanisms that link immediate environmental events to drug use. By simultaneously causing reward centers to send a dopamine signal, nicotine increases the strength of synaptic connections causing memory associations, for example, between the people and the places involved and a drug experience.
Dani graduated summa cum laude from the College of Engineering at the University of Michigan. He earned his doctorate in physiology, with a minor in physical chemistry, at the University of Minnesota. At the University of Washington, he was a postdoctoral fellow in the Department of Physiology and Biophysics with Bertil Hille. He then moved to the University of California at Los Angeles as a postdoctoral fellow with George Eisenman in the Department of Physiology. After three years as a research associate scientist in molecular neurobiology at Yale University, Dani joined Baylor College of Medicine as an assistant professor in 1987. He was named associate professor in 1991 and professor in 1999.
Among Dani’s many honors are the DeBakey Award for outstanding research, from Baylor, and the Jacob Javits Neuroscience Award from the National Institutes of Health. He has been a frequent member of NIH study sections and NIH reviews, including for the NIH Director’s Pioneer Awards. He was a guest editor of a special issue of Journal of Neurobiology and currently serves on the numerous editorial boards.
Penn Medicine is one of the world's leading academic medical centers, dedicated to the related missions of medical education, biomedical research, and excellence in patient care. Penn Medicine consists of the Raymond and Ruth Perelman School of Medicine at the University of Pennsylvania (founded in 1765 as the nation's first medical school) and the University of Pennsylvania Health System, which together form a $5.3 billion enterprise.
The Perelman School of Medicine has been ranked among the top five medical schools in the United States for the past 17 years, according to U.S. News & World Report's survey of research-oriented medical schools. The School is consistently among the nation's top recipients of funding from the National Institutes of Health, with $409 million awarded in the 2014 fiscal year.
The University of Pennsylvania Health System's patient care facilities include: The Hospital of the University of Pennsylvania and Penn Presbyterian Medical Center -- which are recognized as one of the nation's top "Honor Roll" hospitals by U.S. News & World Report -- Chester County Hospital; Lancaster General Health; Penn Wissahickon Hospice; and Pennsylvania Hospital -- the nation's first hospital, founded in 1751. Additional affiliated inpatient care facilities and services throughout the Philadelphia region include Chestnut Hill Hospital and Good Shepherd Penn Partners, a partnership between Good Shepherd Rehabilitation Network and Penn Medicine.
Penn Medicine is committed to improving lives and health through a variety of community-based programs and activities. In fiscal year 2014, Penn Medicine provided $771 million to benefit our community.
Department of Communications
For Patients and the General Public: